UMeWorld Inc. Reports Revenue Surge to $147,455 Amid Increased Losses in Latest 10-Q Filing

UMeWorld Inc. reported significant financial developments in its latest 10-Q filing for the quarter ending December 31, 2025. The company generated revenue of $147,455, a substantial increase from just $195 in the same period last year. This growth was primarily driven by the fulfillment of an initial distributor purchase order in China, marking the company's entry into the Asia-Pacific market. However, the cost of revenues also rose sharply to $142,913 from $2,583, reflecting increased sales volume and associated costs. Consequently, UMeWorld recorded a gross profit of $4,542, a notable recovery from a gross loss of $2,388 in the prior year.

Despite the increase in revenue, UMeWorld's net loss widened to $138,727 for the quarter, compared to a loss of $14,710 in the previous year. This increase in losses was attributed to higher operating expenses, which surged to $143,296 from $12,322, driven by professional fees, increased executive compensation, and costs associated with corporate restructuring. The company's accumulated deficit as of December 31, 2025, stood at $32,068,371, reflecting ongoing financial challenges.

Operationally, UMeWorld has made strategic moves to enhance its market presence. The company completed its redomiciliation from the British Virgin Islands to Delaware on October 2, 2025, transitioning to a U.S. domestic issuer for SEC reporting purposes. Additionally, UMeWorld established a holding structure in the Asia-Pacific region, acquiring Dagola Hong Kong Limited and its subsidiary, Guangzhou Duokanglong Special Medical Nutrition Technology Co., Ltd., which began revenue-generating activities in December 2025. The company also reported an increase in finished goods inventory to $1,682,509, primarily due to initial stocking for distributor orders.

As of the end of December 2025, UMeWorld faced a working capital deficiency of approximately $462,599, raising concerns about its ability to continue as a going concern. The company is actively pursuing additional business arrangements and financing options to support its operations and growth initiatives. Management has indicated that it will seek capital through promissory notes, private placements, and other financing transactions, although there is no assurance that such financing will be available on acceptable terms.

Looking ahead, UMeWorld aims to expand its distribution channels and product offerings in the functional nutrition market. The company is focused on leveraging its DAG-based cooking oil products and enhancing its operational capabilities to drive revenue growth. However, the ongoing reliance on a limited number of distribution partners and the challenges associated with its current financial position present significant risks to its future performance.